Additional Companies' Quarterly and Year-End Results.Affymetrix reported fourth quarter revenues of $59.4 million, a 70.1% increase compared to fourth quarter 1999 revenues. FY 2000 sales rose 84.1% to $200.8 million on sales of more than 200,000 GeneChip arrays and more than 150 GeneChip systems. Operating losses operating loss The excess of operating expenses over revenue. As with operating income, operating losses exclude revenues and expenses from operations that are not considered a regular part of the business. Also called deficit. Compare operating income. for the fourth quarter and the year were $23.6 million and $40.9 million, respectively. Analytik Jena reported first quarter revenues ended December 31, 2000 of EUR EUR In currencies, this is the abbreviation for the Euro. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 8.0 million (EUR1.15=$1=$7.0 million), a 38.8% increase over last year. Almost half of Analytic an·a·lyt·ic or an·a·lyt·i·cal adj. 1. Of or relating to analysis or analytics. 2. Expert in or using analysis, especially one who thinks in a logical manner. 3. Psychoanalytic. Jena's sales, EUR3.6 million (EUR1.15=$1=$3.1 million), came from its Analytical Solutions segment. Its Lab Solutions business unit recorded sales of EUR3.2 million (EUR1.15=$1=$2.8 million), while its Bioanalytical Solutions segment, contributed sales of EUR0.4 million (EUR1.15=$1=$0.4 million). Beckman Coulter's Life Science Research segment reported fourth quarter sales of $132 million, a 4.5% increase over a year ago. FY sales in this segment rose 6.2% to $414.7 million. This segment is comprised of a Robotic ro·bot·ic adj. Relating to, characteristic of, or employing robots. Automation/Genetic Analysis division and a Centrifuge/Analytical Systems divison. The latter makes up about two-thirds of all sales to the Life Science segment. For the year, Life Science Research sales to America rose 9.6%, while sales to Asia rose 13.8% and sales to Europe decreased 5.1%. Bio-Rad's fourth quarter sales fell 9.1% to $177.8 million while FY sales grew 30.7% to $725.9 million. Fourth quarter operating profits Operating profit (or loss) Revenue from a firm's regular activities less costs and expenses and before income deductions. operating profit See operating income. rose to $14.9 million from an operating loss of $3.1 million. Operating profits for the year rose 101.7% to $66.8 million. Bio-Rad's Life Science segment reported year-on-year sales growth of 13%. Genomic genomic pertaining to a genome. genomic clone see clone. genomic DNA the DNA sequences making up the genome of an individual. genomic library see gene bank. Solutions reported a growth of 62.0% in fourth quarter revenues to $5.5 million, while FY revenues rose 57.8% to $19.1 million. For the fourth quarter, operating losses were $1.5 million down from $2.7 million and for the year, operating losses were $8.4 million from $8.8 million. Sales increased due to Genomic Solutions' Investigator Proteomic System and GeneTAC Biochip biochip Small-scale device, analogous to an integrated circuit, constructed of or used to analyze organic molecules associated with living organisms. One type of theoretical biochip is a small device constructed of large organic molecules, such as proteins, and capable of System. Harvard Bioscienee revenues rose 10.4% in the fourth quarter to $8.5 million and 16.8% for the year to $30.6 million. Operating profits for the quarter rose 14.0% to $1.5 million, while operating profits for the year remained virtually unchanged, down a tenth of a percent to $4.8 million. Invitrogen reported its fourth quarter and FYE FYE For Your Entertainment FYE First Year Experience FYE Fiscal Year End FYE Funding Your Education FYE For Your Eyes (CSD-TV magazine) FYE For Your Enjoyment FYE Full Year Effect FYE First Year Enrichment FYE For Your Edification 2000 results including revenues from Life Technologies after the September 14, 2000 acquisition date. Fourth quarter sales of $143.2 million including Life Technologies were higher than fourth quarter sales of Invitrogen a year ago of $23.9 million. For the year, reported revenues which include the sales of Life Technologies since September 2000 were $246.2 million over sales of $92.9 million which includes only Invitrogen's sales a year ago. If the two companies had been combined for the entire year, total revenues would have been $567.0 million, for a 9.8% increase. The combined companies for the year would have had revenues for molecular biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller products of $366.7 million for growth of 15.1%, while cell culture products would have grown by 1.2% to $200.3 million. Operating income Operating Income The profit realized from a business' own operations. Notes: This would not include income from things such as investments in other firms. Also referred to as operating profit or recurring profit. ended negative primarily due to goodwill and merger-related costs. For the quarter, Invitrogen reported an operating loss of $65.7 million below an operating profit of $5.6 million. For the year, Invitrogen reported an operating loss of $67.3 million below an operating profit of $12.8 million. Mettler-Toledo had fourth quarter sales of $297.9 million, for a 2.1% decrease from a year ago. FY sales rose 2.8% to $1,095.5 million, including the acquisition of Testut-Lutrana. Operating profits rose 52.2% to $36.6 million for the quarter, while yearly operating profits rose 16.2% to $142.8 million. Qiagen reported fourth quarter sales rose 29.1% to $55.8 million, and FY revenues rose 29% to $204.0 million. Operating profits from the quarter rose 254.2% to $11.0 million, while FY operating profits rose 49.4% to $34.9 million. Tecan reported a 48.2% increase in fourth quarter sales to CHF CHF In currencies, this is the abbreviation for the Swiss Franc. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 83 million (CHF 1.75=$1=$47.4 million) over CHF 56 million (CHF 1.54=$1=$36.4 million) and a 41.5% increase in FY sales to CHF 273 million (CHF 1.69=$1=$161.5 million) over CHF 193 million (CHF 1.50=$1=$128.7). 2000 sales in its Genomics and Proteomics pro·te·o·mics n. The analysis of the expression, localization, functions, and interactions of the proteins produced by the genes of an organism. group increased 114.3% to CHF 45 million (CHF 1.69=$1=$26.6 million). Drug Discovery, sales grew 41.8% to CHF 129 million (CHF 1.69=$1=$76.3 million), and Diagnostics sales increased 22.2% over the comparable period to CHF 99 (CHF 1.69=$1=$58.6 million). |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion